The effect of vitamin D supplementation on the brain mapping and behavioral performance of children with ADHD: a double-blinded randomized controlled trials

References

• Sharif Madani MR, Tabatabaei FM, Tabatabaee Z. The relationship between serum vitamin D level and attention deficit hyperactivity disorder. Iran J Child Neurol. 2015;9(4):48.
   PubMedGoogle Scholar
• Dehbokri N, Noorazar G, Ghaffari A, Mehdizadeh G, Sarbakhsh P, Ghaffary S. Effect of vitamin D treatment in children with attention-deficit hyperactivity disorder. World J Pediatr. 2019;15(1):78–84. doi:10.1007/s12519-018-0209-8.
   PubMed Web of Science ®Google Scholar
• Bener A, Kamal M. Predict attention deficit hyperactivity disorder? Evidence-based medicine. Glob J Health Sci. 2014;6(2):47.
   Google Scholar
• Kamal M, Bener A, Ehlayel MS. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? ADHD Attent Deficit Hyperact Disord. 2014;6(2):73–8. doi:10.1007/s12402-014-0130-5.
   Google Scholar
• Miranda P, Cox CD, Alexander M, Danev S, Lakey JR. In quest of pathognomonic/endophenotypic markers of attention deficit hyperactivity disorder (ADHD): Potential of EEG-based frequency analysis and erps to better detect, prevent and manage ADHD. Med Dev Evid Res. 2020;13:115–37. doi:10.2147/MDER.S241205.
   Web of Science ®Google Scholar
• Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and Quantitative Electroencephalography. Clin Neurophysiol. 2003;114(2):171–83.
   PubMed Web of Science ®Google Scholar
• Picken C, Clarke AR, Barry RJ, McCarthy R, Selikowitz M. The theta/beta ratio as an index of cognitive processing in adults with the combined type of attention deficit hyperactivity disorder. Clin EEG Neurosci. 2020;51(3):167–73. doi:10.1177/1550059419895142.
   PubMed Web of Science ®Google Scholar
• Nash JK. Treatment of attention deficit hyperactivity disorder with neurotherapy. Clinical Electroencephalography. 2000;31(1):30–7. doi:10.1177/155005940003100109.
   PubMedGoogle Scholar
• Andıran N, Çelik N, Akça H, Doğan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol. 2012;4(1):25–9. doi:10.4274/jcrpe.574.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Nuroendocrinol. 2013;34(1):47–64. doi:10.1016/j.yfrne.2012.07.001.
   PubMed Web of Science ®Google Scholar
• Humble MB, Gustafsson S, Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem Mol Biol. 2010;121(1-2):467–70. doi:10.1016/j.jsbmb.2010.03.013.
   PubMed Web of Science ®Google Scholar
• Villagomez A, Ramtekkar U. Iron, magnesium, vitamin D, and zinc deficiencies in children presenting with symptoms of attention-deficit/hyperactivity disorder. Children. 2014;1(3):261–79. doi:10.3390/children1030261.
   PubMedGoogle Scholar
• Annweiler C, Montero-Odasso M, Muir SW, Beauchet O. Vitamin D and brain imaging in the elderly: should we expect some lesions specifically related to hypovitaminosis D? Open Neuroimag J. 2012;6:16–8. doi:10.2174/1874440001206010016.
   PubMedGoogle Scholar
• Harms LR, Burne TH, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011;25(4):657–69. doi:10.1016/j.beem.2011.05.009.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30. doi:10.1016/j.jchemneu.2004.08.006.
   PubMed Web of Science ®Google Scholar
• Goksugur SB, Tufan AE, Semiz M, Gunes C, Bekdas M, Tosun M, et al. Vitamin D status in children with attention-deficit–hyperactivity disorder. Pediatr Intern. 2014;56(4):515–9. doi:10.1111/ped.12286.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Vitamin D deficiency: infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia). Amer J Physiol Cell Physiol. 2018;314(2):C135–C51. doi:10.1152/ajpcell.00188.2017.
   PubMed Web of Science ®Google Scholar
• Sangouni AA, Mirhosseini H, Hosseinzadeh M. Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial. Trials. 2022;23(1):890), doi:10.1186/s13063-022-06837-1.
   PubMed Web of Science ®Google Scholar
• Felt BT, Biermann B, Christner JG, Kochhar P, Van Harrison R. Diagnosis and management of ADHD in children. Amer Family Physician. 2014;90(7):456–64.
   PubMed Web of Science ®Google Scholar
• Gow RV, Sumich A, Vallee-Tourangeau F, Crawford MA, Ghebremeskel K, Bueno AA, et al. Omega-3 fatty acids are related to abnormal emotion processing in adolescent boys with attention deficit hyperactivity disorder. Prostaglandins Leukotrienes Essent Fatty Acids. 2013;88(6):419–29. doi:10.1016/j.plefa.2013.03.004.
   PubMed Web of Science ®Google Scholar
• Hallal PC, Victora CG. Reliability and validity of the international physical activity questionnaire (IPAQ). Med Sci Sports Exerc. 2004;36(3):556), doi:10.1249/01.MSS.0000117161.66394.07.
   PubMed Web of Science ®Google Scholar
• Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JRJP, et al. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukotrienes Essent Fatty Acids. 2006;75(4-5):299–308.
   PubMed Web of Science ®Google Scholar
• Gottfried RJ, Gerring JP, Machell K, Yenokyan G, Riddle MA. The iron status of children and youth in a community mental health clinic is lower than that of a national sample. Psychopharmacology. 2013;23(2):91–100.
   Web of Science ®Google Scholar
• Gow RV, Hibbeln JRJLT. Omega-3 and treatment implications in Attention Deficit Hyperactivity Disorder (ADHD) and associated behavioral symptoms. Lipid Technol. 2014;26(1):7–10.
   Google Scholar
• Elshorbagy HH, Barseem NF, Abdelghani WE, Suliman HAI, Al-Shokary AH, Abdulsamea SE, et al. Impact of vitamin D supplementation on attention-deficit hyperactivity disorder in children. Ann Pharmacother. 2018;52(7):623–31. doi:10.1177/1060028018759471. Epub 2018/02/20.
   PubMed Web of Science ®Google Scholar
• Mohammadpour N, Jazayeri S, Tehrani-Doost M, Djalali M, Hosseini M, Effatpanah M, et al. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial. J Child Adolsec Pyschopharmacol. 2018;21(3):202–9.
   Google Scholar
• Naeini AA, Fasihi F, Najafi M, Ghazvini MR, Hasanzadeh A. The effects of vitamin D supplementation on ADHD (Attention Deficit Hyperactivity Disorder) in 6–13 year-old students: A randomized, double-blind, placebo-controlled study. Eur J Integr Med. 2019;25:28–33.
   Web of Science ®Google Scholar
• Dehbokri N, Noorazar G, Ghaffari A, Mehdizadeh G, Sarbakhsh P, Ghaffary S. Effect of vitamin D treatment in children with attention-deficit hyperactivity disorder. World J Pediatr. 2019;15(1):78–84.
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ, Johnstone J, Gorman B, Boggis A, Frampton CMJ. Moderators of treatment response in adults with ADHD treated with a vitamin–mineral supplement. Psychiatry. 2014;50:163–71.
   Google Scholar
• Tolppanen A-M, Sayers A, Fraser WD, Lewis G, Zammit S, Lawlor D. The association of 25-hydroxyvitamin D 3 and D 2 with behavioural problems in childhood. PLos One. 2012;7(7):e40097.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Kawasaki K, Noya M, et al. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Mov Disord. 2012;27(2):264–71.
   PubMed Web of Science ®Google Scholar
• Alathari BE, Sabta AA, Kalpana CA, Vimaleswaran KS. Vitamin D pathway-related gene polymorphisms and their association with metabolic diseases: A literature review. J Diab Metab Disord. 2020;19(2):1701–29. doi:10.1007/s40200-020-00561-w. Epub 2021/02/09.
   PubMed Web of Science ®Google Scholar
• Picken C, Clarke AR, Barry RJ, McCarthy R, Selikowitz M. The theta/beta ratio as an index of cognitive processing in adults with the combined type of attention deficit hyperactivity disorder. Clin EEG Neurosci. 2020;51(3):167–73. doi:10.1177/1550059419895142. Epub 2019/12/27.
   PubMed Web of Science ®Google Scholar
• Krepel N, Egtberts T, Sack AT, Heinrich H, Ryan M, Arns M. A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction. NeuroImage: Clin. 2020;28:102399), doi:10.1016/j.nicl.2020.102399.
   PubMed Web of Science ®Google Scholar
• Trammell JP, MacRae PG, Davis G, Bergstedt D, Anderson AE. The relationship of cognitive performance and the theta-alpha power ratio Is Age-dependent: An EEG study of short term memory and reasoning during task and resting-state in healthy young and Old adults. Front Aging Neurosci. 2017;9:364), Epub 2017/11/23.
   PubMed Web of Science ®Google Scholar
• Eyles D, Feron F, Cui X, Kesby J, Harms L, Ko P, et al. Developmental vitamin D deficiency causes abnormal brain development. Pyschoneuroendocrinology. 2009;34:S247–S57.
   PubMedGoogle Scholar
• Tekes K, Gyenge M, Folyovich A, Csaba GJH. Influence of neonatal vitamin A or vitamin D treatment on the concentration of biogenic amines and their metabolites in the adult rat brain. Horm Metab Res. 2009;41(04):277–80.
   PubMedGoogle Scholar
• Jiang P, Zhang L, Cai H, Li H, Liu Y, Tang M, et al. Neurochemical effects of chronic administration of calcitriol in rats. Nutrients. 2014;6(12):6048–59. doi:10.3390/nu6125853.
   PubMed Web of Science ®Google Scholar
• Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NKJP. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013;138(2):155–75.
   PubMed Web of Science ®Google Scholar
• Cui X, Pertile R, Liu P, Eyles DJN. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90–100.
   PubMed Web of Science ®Google Scholar
• Orme RP, Bhangal MS, Fricker RA. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS One. 2013;8(4):e62040), Epub 2013/04/30.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Bonvicini C, Scassellati CJ. Biomarkers in the diagnosis of ADHD–promising directions. Curr Pyschiatry Rep. 2014;16(11):497.
   PubMed Web of Science ®Google Scholar
• Taurines R, Grünblatt E, Schecklmann M, Schwenck C, Albantakis L, Reefschläger L, et al. Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder. World J Biol Psyschiatry. 2011;12(sup1):104–8.
   PubMed Web of Science ®Google Scholar
• Peeyush KT, Savitha B, Sherin A, Anju T, Jes P, Paulose CJPB, et al. Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with Vitamin D3 supplementation. Pharmacol Biochem Behav. 2010;95(2):216–22.
   PubMed Web of Science ®Google Scholar
• Kesby JP, Cui X, O’Loan J, McGrath JJ, Burne TH, Eyles DWJP. Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Pyschopharmacology (Berl). 2010;208(1):159–68.
   PubMed Web of Science ®Google Scholar
• Humble MB. Vitamin D, light and mental health. J Photochem Photobiol B. 2010;101(2):142–9.
   PubMed Web of Science ®Google Scholar
• Goksugur SB, Tufan AE, Semiz M, Gunes C, Bekdas M, Tosun M, et al. Vitamin D status in children with attention-deficit–hyperactivity disorder. Pediatr Int. 2014;56(4):515–9.
   PubMed Web of Science ®Google Scholar
• Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z, et al. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Pyschiatry. 2002;7(8):908–12.
   PubMed Web of Science ®Google Scholar
• Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: Relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29(6):2207–22.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Burne TH, McGrath JJJF. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013;34(1):47–64.
   PubMed Web of Science ®Google Scholar